AGA
CVS icon

Altrinsic Global Advisors’s CVS Health CVS Stock Holding History

Altrinsic Global Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-151,282
Closed -$12.1M – 46
2024
Q1 		$12.1M Sell
151,282
-11,134
-7% -$850K 0.54% 24
2023
Q4 		$12.8M Sell
162,416
-65,731
-29% -$4.68M 0.54% 24
2023
Q3 		$15.9M Sell
228,147
-12,371
-5% -$877K 0.61% 25
2023
Q2 		$16.6M Sell
240,518
-11,086
-4% -$789K 0.64% 26
2023
Q1 		$18.7M Buy
251,604
+48,183
+24% +$4.04M 0.72% 24
2022
Q4 		$19M Sell
203,421
-9,195
-4% -$887K 0.81% 22
2022
Q3 		$20.3M Sell
212,616
-1,729
-0.8% -$171K 0.93% 20
2022
Q2 		$19.9M Sell
214,345
-12,920
-6% -$1.26M 0.81% 24
2022
Q1 		$23M Sell
227,265
-143,031
-39% -$15M 0.8% 23
2021
Q4 		$38.2M Sell
370,296
-68,789
-16% -$6.36M 1.22% 19
2021
Q3 		$37.3M Buy
439,085
+54,963
+14% +$4.6M 1.12% 25
2021
Q2 		$32.1M Sell
384,122
-215
-0.1% -$17.6K 0.97% 30
2021
Q1 		$28.9M Buy
384,337
+7,785
+2% +$567K 0.91% 32
2020
Q4 		$25.7M Sell
376,552
-1,339
-0.4% -$87.1K 0.87% 29
2020
Q3 		$22.1M Buy
377,891
+3,502
+0.9% +$218K 0.9% 29
2020
Q2 		$24.3M Sell
374,389
-8,867
-2% -$558K 1.06% 27
2020
Q1 		$22.7M Buy
383,256
+22,148
+6% +$1.48M 1.25% 26
2019
Q4 		$26.8M Sell
361,108
-24,952
-6% -$1.75M 1.13% 28
2019
Q3 		$24.3M Buy
386,060
+38,617
+11% +$2.29M 1.05% 28
2019
Q2 		$18.9M Sell
347,443
-9,098
-3% -$490K 0.88% 30
2019
Q1 		$19.2M Buy
356,541
+94,300
+36% +$5.82M 0.89% 33
2018
Q4 		$17.2M Buy
262,241
+7,315
+3% +$546K 0.82% 35
2018
Q3 		$20.1M Buy
254,926
+191,926
+305% +$13.7M 0.91% 34
2018
Q2 		$4.05M Buy
+63,000
New +$4.15M 0.16% 54

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Altrinsic Global Advisors's CVS Position: Q2 2024 in Review

Altrinsic Global Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 151,282 shares — an estimated $12.1M sold.

Altrinsic Global Advisors first reported a position in CVS in Q2 2018 and held it in 24 quarters. The position peaked at $38.2M in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Altrinsic Global Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Altrinsic Global Advisors sold 151,282 CVS Health shares in Q2 2024, an estimated $12.1M.
  • Altrinsic Global Advisors first reported a position in CVS Health in Q2 2018 and held it in 24 quarters.
  • Altrinsic Global Advisors's CVS Health position peaked at $38.2M in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Altrinsic Global Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.